Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COFFEE
NCT03878277Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Jul 2019
- Primary completion
- Jan 2020
- Modality
- Dietary Supplement
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Caffeinated coffee in diabetic kidney disease (DKD), sponsored by University of Colorado Denver. Primary endpoints: Renal Oxygenation at 1 hour and Renal Perfusion at 1 hour. Started Jul 2019; status: completed.
02
Drugs
Caffeinated coffee
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT03878277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03878277.